InfoBionic

InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiac arrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data.

InfoBionic headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Medical Device, Health Diagnostics sector. The company focuses on Biotechnology and has secured $36.3B in funding across 240 round(s). With a team of 11-50 employees, InfoBionic is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - InfoBionic, raised $969.0K. Discover more about their projects, partnerships, and impact on our platform.